• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间皮瘤中的NF2改变。

NF2 alteration in mesothelioma.

作者信息

Sekido Yoshitaka, Sato Tatsuhiro

机构信息

Division of Cancer Biology, Aichi Cancer Center Research Institute, Nagoya, Japan.

Division of Molecular and Cellular Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Front Toxicol. 2023 Apr 25;5:1161995. doi: 10.3389/ftox.2023.1161995. eCollection 2023.

DOI:10.3389/ftox.2023.1161995
PMID:37180489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10168293/
Abstract

The tumor suppressor gene is a frequent somatically mutated gene in mesothelioma, with 30%-40% mesotheliomas showing inactivation. encodes merlin, a member of the ezrin, radixin, and moesin (ERM) family of proteins that regulate cytoskeleton and cell signaling. Recent genome analysis revealed that alteration may be a late event in mesothelioma development, suggesting that mutation confers a more aggressive phenotype to mesothelioma cells and may not be directly caused by asbestos exposure. The Hippo tumor-suppressive and mTOR prooncogenic signaling pathways are crucial cell-signaling cascades regulated by merlin. Although the exact role and timing of inactivation in mesothelioma cells remain to be elucidated, targeting the /merlin-Hippo pathway may be a new therapeutic strategy for patients with mesothelioma.

摘要

肿瘤抑制基因是间皮瘤中常见的体细胞突变基因,30%-40%的间皮瘤显示该基因失活。它编码merlin,merlin是埃兹蛋白、根蛋白和膜突蛋白(ERM)家族的成员,该家族蛋白调节细胞骨架和细胞信号传导。最近的基因组分析表明,该基因改变可能是间皮瘤发生过程中的晚期事件,这表明该基因突变赋予间皮瘤细胞更具侵袭性的表型,且可能并非直接由石棉暴露引起。Hippo肿瘤抑制信号通路和mTOR促癌信号通路是由merlin调节的关键细胞信号级联反应。尽管该基因在间皮瘤细胞中失活的确切作用和时间仍有待阐明,但靶向该基因/merlin-Hippo信号通路可能是间皮瘤患者的一种新治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2226/10168293/91959c7a5600/ftox-05-1161995-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2226/10168293/682ed561ac92/ftox-05-1161995-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2226/10168293/91959c7a5600/ftox-05-1161995-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2226/10168293/682ed561ac92/ftox-05-1161995-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2226/10168293/91959c7a5600/ftox-05-1161995-g002.jpg

相似文献

1
NF2 alteration in mesothelioma.间皮瘤中的NF2改变。
Front Toxicol. 2023 Apr 25;5:1161995. doi: 10.3389/ftox.2023.1161995. eCollection 2023.
2
NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.神经纤维瘤病 2 型/ Merlin 失活与间皮瘤的潜在治疗靶点。
Int J Mol Sci. 2018 Mar 26;19(4):988. doi: 10.3390/ijms19040988.
3
Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation.恶性间皮瘤细胞中 Merlin 的失活和 Hippo 信号级联的失调。
Pathol Int. 2011 Jun;61(6):331-44. doi: 10.1111/j.1440-1827.2011.02666.x. Epub 2011 May 2.
4
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity.神经纤维瘤病2型:癌症代谢重编程和肿瘤免疫中被低估的因素
NPJ Precis Oncol. 2024 Jun 15;8(1):133. doi: 10.1038/s41698-024-00627-5.
5
Merlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival.Merlin 是一种“神奇”的连接蛋白,能够连接细胞外信号和细胞内信号通路,调节细胞的运动、增殖和存活。
Curr Protein Pept Sci. 2010 Sep;11(6):471-84. doi: 10.2174/138920310791824011.
6
Conformational flexibility determines the Nf2/merlin tumor suppressor functions.构象灵活性决定了Nf2/默林肿瘤抑制因子的功能。
Matrix Biol Plus. 2021 Jul 1;12:100074. doi: 10.1016/j.mbplus.2021.100074. eCollection 2021 Dec.
7
Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma.靶向河马通路是恶性间皮瘤一种新的潜在治疗方式。
Cancers (Basel). 2018 Mar 22;10(4):90. doi: 10.3390/cancers10040090.
8
Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.抑癌基因改变通过 p53-miR-34a-c-Met 轴合作驱动富含肿瘤干细胞的侵袭性间皮瘤。
Cancer Res. 2014 Feb 15;74(4):1261-1271. doi: 10.1158/0008-5472.CAN-13-2062. Epub 2013 Dec 26.
9
A mouse model recapitulating molecular features of human mesothelioma.一种概括人类间皮瘤分子特征的小鼠模型。
Cancer Res. 2005 Sep 15;65(18):8090-5. doi: 10.1158/0008-5472.CAN-05-2312.
10
Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.神经纤维瘤病2型(NF2)肿瘤抑制蛋白(默林)的两种亚型之间以及默林与埃兹蛋白之间的相互作用,提示默林对ERM蛋白具有调节作用。
J Neurosci Res. 2000 Nov 15;62(4):491-502. doi: 10.1002/1097-4547(20001115)62:4<491::AID-JNR3>3.0.CO;2-D.

引用本文的文献

1
Pleural Mesothelioma: Pathogenesis, Diagnosis, Treatment, Prognosis, and Survival.胸膜间皮瘤:发病机制、诊断、治疗、预后及生存情况
MedComm (2020). 2025 Sep 1;6(9):e70327. doi: 10.1002/mco2.70327. eCollection 2025 Sep.
2
Pleural mesothelioma.胸膜间皮瘤
Nat Rev Dis Primers. 2025 Aug 7;11(1):56. doi: 10.1038/s41572-025-00640-3.
3
De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.从头嘧啶合成是NF2缺陷型间皮瘤中的一种附带代谢脆弱性。
EMBO Mol Med. 2025 Jul 24. doi: 10.1038/s44321-025-00278-4.
4
Targeting the Hippo pathway in cancer.靶向癌症中的Hippo信号通路。
Nat Rev Drug Discov. 2025 Jun 30. doi: 10.1038/s41573-025-01234-0.
5
Malignant Pleural Mesothelioma: From Pathophysiology to Innovative Actionable Targets.恶性胸膜间皮瘤:从病理生理学到创新的可操作靶点
Cancers (Basel). 2025 Mar 30;17(7):1160. doi: 10.3390/cancers17071160.
6
Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review).间皮瘤中的端粒与端粒酶:病理生理学、生物标志物及新兴治疗策略(综述)
Int J Oncol. 2025 Mar;66(3). doi: 10.3892/ijo.2025.5729. Epub 2025 Feb 21.
7
Cooperation between the Hippo and MAPK pathway activation drives acquired resistance to TEAD inhibition.Hippo信号通路与MAPK信号通路激活之间的协同作用驱动了对TEAD抑制的获得性耐药。
Nat Commun. 2025 Feb 18;16(1):1743. doi: 10.1038/s41467-025-56634-y.
8
Diagnostic Challenges in the Pathological Approach to Pleural Mesothelioma.胸膜间皮瘤病理诊断方法中的挑战
Cancers (Basel). 2025 Feb 1;17(3):481. doi: 10.3390/cancers17030481.
9
Synergistic effect of PAK and Hippo pathway inhibitor combination in NF2-deficient Schwannoma.NF2 缺陷型神经鞘瘤中 PAK 和 Hippo 通路抑制剂联合的协同作用。
PLoS One. 2024 Jul 31;19(7):e0305121. doi: 10.1371/journal.pone.0305121. eCollection 2024.
10
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity.神经纤维瘤病2型:癌症代谢重编程和肿瘤免疫中被低估的因素
NPJ Precis Oncol. 2024 Jun 15;8(1):133. doi: 10.1038/s41698-024-00627-5.